Latest News about MASI
Recent news which mentions MASI
Stocks That Hit 52-Week Highs On Friday
January 17, 2020
From Benzinga
The Daily Biotech Pulse: Novo Nordisk's Ozempic Receives Label Expansion For Cardiovascular Events, Adcom Disappointment Inflicts Pain On Durect Shares
January 17, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
January 16, 2020
From Benzinga
The Daily Biotech Pulse: Osmotica Soars On Insider Buys, Ultragenyx's Partnered Rare Disease Drug Moves Into Clinics
January 16, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
January 15, 2020
From Benzinga
The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug
January 14, 2020
From Benzinga
Apple Sued for Patent Infringement by Masimo and Affiliate
January 10, 2020
From Motley Fool
Stocks That Hit 52-Week Highs On Friday
January 10, 2020
From Benzinga
The Daily Biotech Pulse: Positive Data Readouts To Spur Aclaris, Moderna And Ultragenyx
January 10, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
January 09, 2020
From Benzinga
Is Masimo's Stock a Buy?
December 15, 2019
From Motley Fool
Masimo's Momentum Keeps Going in Q3 With Solid Earnings Growth
October 31, 2019
Tickers
MASI
From Motley Fool
The Daily Biotech Pulse: Novartis Program Placed On Partial Clinical Hold, Adcom Snub For Amag, Amgen Earnings
October 30, 2019
From Benzinga
3 Top Healthcare Stocks to Buy in October
October 05, 2019
From Motley Fool
Checking the Performance of 5 Mm-Mm Good Stocks, 1 Year Later
September 23, 2019
From Motley Fool
The Daily Biotech Pulse: Roche Snags Double Nod For Personalized Cancer Drug, Bellicum Offering, Nabriva Braces For Contepo Resubmission
August 16, 2019
From Benzinga
Tickers
MASI
From Motley Fool
Companies That Achieved 52-Week Highs Friday
July 26, 2019
From Benzinga
The Daily Biotech Pulse: Setback For Bristol-Myers Squibb, Gemphire Explodes, Lilly's Nasal Low Blood Sugar Drug
July 25, 2019
From Benzinga
The Daily Biotech Pulse: Hookipa Leaps, Illumina Dims On Q2 Warning, Novartis-Amgen Halt Alzheimer's Study
July 12, 2019
From Benzinga
4 Lower-Risk Healthcare Picks for Long-Term Investors
June 28, 2019
From Motley Fool
The Daily Biotech Pulse: Axovant Doses First Patient In Gene Therapy Trial, Agile Resubmits NDA, ADMA Prices Offering
May 17, 2019
From Benzinga
Tickers
MASI
From Motley Fool
Earnings Scheduled For May 6, 2019
May 06, 2019
From Benzinga
Interview: Talking Decking, Diets, and Discounts With the Polen Small Company Growth Team
April 18, 2019
From Motley Fool
Benzinga's Top Upgrades, Downgrades For April 16, 2019
April 16, 2019
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.